Therefore GLP-1 drugs, even if they have received FDA approval for weight loss, are not covered under Part D drugs when used for that purpose
Originally isolated from human gastric juice in the early 1990s by Croatian researchers, this 15-amino acid peptide has demonstrated an almost paradoxical ability to promote healing across diverse tissue types throughout the body
These dysesthesia events were generally mild and rarely led to treatment discontinuation
Fortunately for me, my weight-loss journey both started and ended in 2015, before GLP-1 drugs were widely available, so I never had to worry about an asterisk being placed next to my name
In addition to the classical functions of cAMP, the cAMP/CREB pathway can induce the expression of insulin receptor substrate 2 (IRS2) and promote -cell survival, further demonstrating the protective effects of GLP-1 analogs on -cells [7] [8] [9] [10]